Clinical Trial Update: Ph II CABOGIST in GIST [Phase 2]

View source ↗

Summary

Phase II trial update for CABOGIST in metastatic gastrointestinal stromal tumor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• CABOGIST

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Metastatic Gastrointestinal Stromal Tumor | Phase 2 | Status: COMPLETED